Teneliximab (Chi220) is a chimeric monoclonal antibody and a tumor necrosis factor receptor superfamily member 5 (CD40) inhibitor that blocks CD40-CD40L interactions.Teneliximab exerts partial agonist activity through CD40 and peripheral B-cell depletion
CAS Number:
[299423-37-3]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted